一个三级中心的经验,患者与同时的甲状腺髓癌和乳头甲状腺癌
Georgios Boutzios1, Zoe Garoufalia2, Myrto D Keramida2
1Endocrine Unit, Department of Pathophysiology, National and Kapodistrian University of Athens, Mikras Asias 75, Goudi-Attica, 11527, Athens, PC, Greece. gboutzios@med.uoa.gr.
概括
这项研究发现,状甲状腺癌 (PTC) 和状甲状腺癌 (MTC) 与患者的年龄或性别等因素并无关联. 这些发现表明,MTC患者的PTC可能是一个偶然的二次发现.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 乳头甲状腺癌 (PTC) 和骨髓甲状腺癌 (MTC) 起源于不同的胚胎组织.
- 已经报告了PTC和MTC在同一淋巴结中的共存,称为混合髓/状甲状腺癌 (MMFTC).
- 同时使用MTC和PTC的临床意义和相关性尚不清楚.
研究的目的:
- 调查MTC患者中PTC的患病率.
- 确定患有同时存在MTC和PTC的患者的临床表型.
- 探索MTC/PTC与临床因素 (如年龄,癌胚抗原 (CEA),素水平,性别和手术数量) 之间的潜在关联.
主要方法:
- 一个回顾性观察性研究是在一个单一的高等大学医院进行的.
- 包括30名在2017年11月至2021年3月期间被诊断为MTC/PTC的患者,不包括那些阳性RET.
- 使用SPSS软件进行了统计分析,包括单变量和多变量分析.
主要成果:
- 该研究包括30名MTC/PTC患者,平均年龄为58.43岁;53.3%是男性.
- 单变体和多变体分析显示,MTC/PTC共存与年龄,素水平,CEA,性别,转移数量或手术数量之间没有显著的关联.
- 样本规模有限限制了多变量分析的范围.
结论:
- 在这个队列中,同时使用MTC/PTC与患者人口统计学或临床标志物之间没有发现关联.
- MTC和PTC的共存可能代表第二种恶性瘤的偶然发现,而不是一个不同的临床实体.
- 需要进一步研究更大的样本大小来证实这些发现.
相关概念视频
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...


